Biolitec Revenue and Competitors
Employee Data
- Biolitec has 151 Employees.
- Biolitec grew their employee count by 1% last year.
Biolitec's People
Name | Title | Email/Phone |
---|---|---|
1 | Managing Director & CEO at biolitec Latin America | Reveal Email/Phone |
2 | Head Organizational Development | Reveal Email/Phone |
3 | Global Business and Market Development Director | Reveal Email/Phone |
4 | Sales & Clinical Manager | Reveal Email/Phone |
5 | Area Sales Manager | Reveal Email/Phone |
6 | Responsable commercial / Sales manager | Reveal Email/Phone |
7 | Manager R&D / Technical Files | Reveal Email/Phone |
8 | Sales Manager Middle East | Reveal Email/Phone |
9 | Country Manager | Reveal Email/Phone |
10 | Responsable Commerciale / Sales Manager | Reveal Email/Phone |
Biolitec Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 55 | 38% | N/A | N/A |
#2 | N/A | 151 | 1% | N/A | N/A |
#3 | N/A | 53 | 33% | N/A | N/A |
#4 | N/A | 77 | 43% | N/A | N/A |
#5 | N/A | 37 | 37% | N/A | N/A |
#6 | N/A | 69 | 25% | N/A | N/A |
#7 | N/A | 61 | 91% | N/A | N/A |
What Is Biolitec?
Biolitec is a global medical device company specialising in medical laser and fibre technology. With 30 years' of technology expertise, we strive to bring innovation that adds value to physicians and patients. Biolitec is the only company that has the all relevant core competencies in photodynamic therapy. With presence in approximately 100 countries, we collaborate with our customers to enhance patient outcomes, shorten treatment times, achieve quick recovery.
keywords:N/AN/A
Total Funding
151
Number of Employees
N/A
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $39.8M | 151 | -11% | $514M |
#2 | $38M | 152 | 42% | N/A |
#3 | $7.5M | 157 | 8% | N/A |
#4 | $20.7M | 157 | 32% | N/A |
#5 | $28.2M | 157 | 7% | N/A |